Pharma-Bio Serv (PBSV) Expected to Announce Earnings on Monday

Pharma-Bio Serv (OTCMKTS:PBSV) is expected to be releasing its earnings data on Monday, January 27th. Analysts expect Pharma-Bio Serv to post earnings of $0.03 per share and revenue of $4,000.00 billion for the quarter.

Pharma-Bio Serv Price Performance

Shares of PBSV stock opened at $0.58 on Monday. The firm has a fifty day moving average of $0.52 and a two-hundred day moving average of $0.58. The firm has a market cap of $13.32 million, a P/E ratio of -19.33 and a beta of 0.51. Pharma-Bio Serv has a 1-year low of $0.31 and a 1-year high of $1.08.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.